We are live on ! Find out more
NUVB.WS

Nuvation Bio Inc Warrants
NUVB.WS

Delisted

NUVB.WS was delisted on the 10th of February, 2026.

Back to rankings

22 hedge funds and large institutions have $18.3M invested in Nuvation Bio Inc Warrants in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $18M → $18.3M (+$375K)

4% less funds holding

Funds holding: 23 → 22 (-1)

21.06% less ownership

Funds ownership: 22.97% → 1.91% (-21%)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
2
Calls
$79K
Puts
–
Net Calls
+$79K
Net Calls Change
-$19K

Top Buyers

Rank Fund Capital Flow
1
CC
Clearline Capital
New York
+$77.9K

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$217K
2
CAC
Cowen and Company
New York
-$68K
3
UBS Group
UBS Group
Switzerland
-$4.22K
4
IP
Intellectus Partners
California
-$780
5
Citadel Advisors
Citadel Advisors
Florida
-$489
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$9.58M – – –
6CM
2
683 Capital Management
New York
$2.11M – – –
HCM
3
Highbridge Capital Management
New York
$948K – – –
Franklin Resources
4
Franklin Resources
California
$709K – – –
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$683K – – –
BC
6
Boxer Capital
California
$683K – – –
BlackRock
7
BlackRock
New York
$589K – – –
CCA
8
Castle Creek Arbitrage
Colorado
$573K – – –
DM
9
Deerfield Management
New York
$427K – – –
RSCM
10
Rock Springs Capital Management
Maryland
$343K – – –
GC
11
Greenlight Capital
New York
$256K – – –
APM
12
Avidity Partners Management
Texas
$253K – – –
ACP
13
Acuta Capital Partners
California
$242K – – –
Citadel Advisors
14
Citadel Advisors
Florida
$188K -$489 -209 -0.3%
LGM
15
Logos Global Management
California
$177K – – –
Victory Capital Management
16
Victory Capital Management
Texas
$174K – – –
MA
17
MYDA Advisors
New York
$101K – – –
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$90K – – –
CC
19
Clearline Capital
New York
$85K +$77.9K +33,271 New
MIM
20
Monashee Investment Management
Massachusetts
$68K – – –
IP
21
Intellectus Partners
California
$66K -$780 -333 -1%
UBS Group
22
UBS Group
Switzerland
$5K -$4.22K -1,801 -47%
Walleye Capital
23
Walleye Capital
New York
$418 – – –
CAM
24
Cormorant Asset Management
Massachusetts
– -$217K -83,332 Closed
CAC
25
Cowen and Company
New York
– -$68K -26,250 Closed

NUVB.WS Hedge Fund Activity: Q3 2021 in Review

22 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q3 2021, worth a combined $18.3M — up 2.1% from $18M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NUVB.WS and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.

The largest buyer was Clearline Capital, opening a new position worth an estimated $77.9K. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $217K sold.

  • 22 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q3 2021, down from 23 in Q2 2021.
  • Funds reported $18.3M of Nuvation Bio Inc Warrants stock for Q3 2021, up 2.1% quarter-over-quarter.
  • 1 fund opened new Nuvation Bio Inc Warrants positions in Q3 2021 and 2 closed out, a net change of -1 holder.
  • The largest Nuvation Bio Inc Warrants buyer in Q3 2021 was Clearline Capital, an estimated $77.9K added.
  • The largest Nuvation Bio Inc Warrants seller in Q3 2021 was Cormorant Asset Management, an estimated $217K sold.

Based on aggregated 13F filings for Q3 2021.